DrugPatentWatch Database Preview
Drugs in Development Information for Navitoclax
Summary for Navitoclax
| US Patents | 132 |
| International Patents | 1,599 |
| US Patent Applications | 260 |
| WIPO Patent Applications | 105 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2011-10-01) |
| Vendors | 63 |
US Patents for Navitoclax
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Navitoclax | ➤ Sign Up | Substituted indole Mcl-1 inhibitors | Vanderbilt University (Nashville, TN) | ➤ Sign Up |
| Navitoclax | ➤ Sign Up | Antibody drug conjugates | Novartis AG (Basel, CH) | ➤ Sign Up |
| Navitoclax | ➤ Sign Up | Apoptosis promoters | Abbott Laboratories (Abbott Park, IL) | ➤ Sign Up |
| Navitoclax | ➤ Sign Up | Apoptosis promoters | Abbott Laboratories (Abbott Park, IL) | ➤ Sign Up |
| Navitoclax | ➤ Sign Up | Treatment of myeoproliferative diseases | Abbott Laboratories (Abbott Park, IL) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for Navitoclax
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Navitoclax | Canada | 2922341 | 2033-08-28 | ➤ Sign Up |
| Navitoclax | European Patent Office | 3038618 | 2033-08-28 | ➤ Sign Up |
| Navitoclax | World Intellectual Property Organization (WIPO) | 2015031608 | 2033-08-28 | ➤ Sign Up |
| Navitoclax | Argentina | 102649 | 2034-11-14 | ➤ Sign Up |
| Navitoclax | Australia | 2015347015 | 2034-11-14 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
